BMJ Best Practice Podcast

International travel is increasingly common. Between 10% and 42% of travellers to any destination, and 15%-70% of travellers to tropical settings experience ill health, either while abroad or on returning home, Malaria is the commonest specific diagnosis, accounting for 5%-29% of all individuals presenting to specialist clinic, followed by dengue, enteric fever, and rickettsial infections . In this podcast Doug Fink specialist registrar, and Victoria Johnston consultant, in infectious diseases at The Hospital for Tropical Diseases join us to discuss diagnosis, and treatment - and why the clinically most interesting diagnosis is rarely the right one. Read the full practice article: www.bmj.com/content/360/bmj.j5773 This podcast was produced by The BMJ. _ The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Dr Mary-Margaret Fill currently works as a Medical Epidemiologist in Communicable and Environmental Diseases and Emergency Preparedness at the Tennessee Department of Health. To learn more about Avian Influenza, visit BMJ Best Practice. http://bestpractice.bmj.com/topics/en-gb/455 _ The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Christopher Paddock, Medical Officer and pathologist in the Rickettsial Zoonoses Branch in CDC’s Division of Vector-Borne Diseases, gives a clinical guide to recognising and managing typhus group rickettsiae. For more on typhus group rickettsiae, take a look at Best Practice: http://bestpractice.bmj.com/topics/en-gb/1604 _ The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

A clinical guide to recognising and managing Tularaemia. Dr Isaac Bogoch is a clinical researcher, Toronto General Hospital Research Institute, Canada. To learn more about Tularaemia Infection, visit BMJ Learning https://goo.gl/7kRgeu And BMJ Best Practice bestpractice.bmj.com/topics/en-gb/916 _ The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Dr. Matthieu Million discusses Coxiella Burnetii infection, including transmission through animals, risks of prolonged fever and fatal outcomes, importance of PCR for early detection, tailored antibiotic therapy, prevention of endocarditis, and recent advances in diagnostic protocols.

Learn about the new 2017 AHA/ACC guidelines on hypertension, including changes to definition, self-monitoring, and management. Discover the implications on diagnosis and treatment, use of out-of-office blood pressure readings, medications like spironolactone, and discrepancies in guidelines. Dive into the Sprint Trial's impact on blood pressure goals, patient selection, and controversies in hypertension management.

Explore the origins and symptoms of the plague, with insights on diagnosing and managing Yersinia from Dr. Amesh Adalja. Learn about historical significance, clinical characteristics, isolation measures, and challenges in diagnosing and preparing for plague cases.

Dr. Claudia Kraft discusses the challenges of diagnosing and treating botulism in the Arctic, emphasizing collaboration among physicians. The rise of botulism cases in Arctic coastal areas from marine sediment contamination is explored. Recognizing symptoms like dry mouth and muscle weakness, along with the importance of urgent referral for respiratory support and antitoxin, is highlighted. Key clinical features to differentiate botulism from other conditions are discussed, along with common pitfalls in diagnosis and management.

Dr. Tom Fletcher discusses his experiences treating Ebola in West Africa, emphasizing patient recognition, treatment, and isolation procedures. He addresses challenges in managing Ebola, provides guidance for healthcare professionals, and highlights WHO guidelines for supportive care.

Discussion on hepatitis C infection with focus on treatment advancements using oral direct-acting agents. Topics include transmission, testing procedures, genotype relevance, post-treatment considerations, advanced liver disease treatment, and long-term effects of antiviral treatment.